Sign in
CompletedNo phase

Pilot Testing a Digital Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness

Key facts

Who runs it
University of Maryland, Baltimore
Where
Baltimore, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
59 people enrolled
Started
6 Sept 2022
Ended
25 Mar 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • BecomeAnEX
  • Usual Care
Record updated
15 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (11)Hide the full registry criteria

Who can take part

  • Age 18 or greater
  • Diagnosis of serious mental illness (schizophrenia, schizoaffective disorder, bipolar disorder, or major depression)
  • Current smoker [prior to admission, smoked at least one cigarette or small cigar per day in the past month (unless restricted, e.g. due to ER/hospital visit) and smoked at least 100 cigarettes lifetime]
  • Interested in remaining quit after hospital discharge or quitting within the following 30 days
  • Expected Internet use at least 3 times/week post-discharge and ownership of mobile device with text messaging plan post-discharge
  • Discharge destination within 1-hour of SPH given that Aim 3 involves biochemical verification (carbon monoxide testing)
  • Reading competence as demonstrated by a score of >= 37 on the Word Reading subtest of the Wide Range Achievement Test - 4th Edition (WRAT-4)168 to ensure the ability to engage in the intervention

Who cannot take part

  • Homeless prior to admission or anticipated to be homeless at discharge
  • Medical condition for which the use of nicotine replacement therapy (NRT) is contraindicated including pregnant, planning to become pregnant, or breastfeeding; within 4 weeks post myocardial infarction; severe arrhythmia, severe angina pectoris; peptic ulcer; severe renal failure; poorly controlled insulin-dependent diabetes; severely uncontrolled hypertension; peripheral vascular disease
  • Intellectual disability (DSM5 317, 318), traumatic brain injury, or deafness
  • Discharge to a residential setting where smoking is prohibited

Where in United States

  • Melanie BennettBaltimore, United States
  • University of Maryland School of MedicineBaltimore, United States

About the trial

What the trial wants to find out

All patients with serious mental illness are abstinent while in the hospital for a psychiatric admission yet almost all return to smoking after discharge. The investigators propose to test a digital intervention adapted to the needs of SMI smokers and to being introduced in the inpatient psychiatric setting. Such an intervention could bridge the inpatient to outpatient gap in cessation services and will help people remain abstinent following hospital discharge.

The 2 groups in the trial

  • BecomeAnEXTreatment being tested

    Participants will have three individual meetings with a research staff person while they are in the hospital. At these meetings participants will answer questions about their smoking and interest in quitting, learn about BecomeAnEx, and register with the BecomeAnEx program so that they can use it when you leave the hospital. Participants will be given two weeks of nicotine replacement therapy when they leave the hospital. Participants will be asked to use BecomeAnEx as much as they want when they leave the hospital.

    Treatment: BecomeAnEX and Usual Care

  • Usual CareExisting treatment, for comparison

    Brief individual counseling, NRT during the hospital stay and a prescription for NRT at discharge (consistent with standard hospital procedures), and referral to the MD quitline.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
15 July 2026